Sequenom, Inc. (NASDAQ: SQNM) is focused on providing superior genetic analysis products designed to translate genomic science into advanced solutions for biomedical research, agricultural applications, molecular medicine and non-invasive prenatal diagnostics research, and possibly clinical utility. MassARRAY, the company’s high-performance DNA analysis platform, efficiently and precisely measures the amount of genetic target material as well as the variations within. For further information, visit the Company’s web site at www.sequenom.com.
- 17 years ago
QualityStocks
Sequenom, Inc. (NASDAQ: SQNM)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Gloo Holdings, Inc. (NASDAQ: GLOO) Prices $72.8 Million IPO
Gloo (NASDAQ: GLOO) , a technology platform serving the faith and flourishing ecosystem, priced its…
-
QualityStocksNewsBreaks – Safe Pro Group Inc. (NASDAQ: SPAI) Positioned for Growth as War Department Launches Billion-Dollar Push for U.S. Drone Dominance
Safe Pro Group (NASDAQ: SPAI), a mission-driven provider of AI-powered defense and security solutions, is…
-
QualityStocksNewsBreaks – Decent Holding Inc. (NASDAQ: DXST) Closes $8 Million Registered Offering of Class A Shares and Warrants
Decent Holding (NASDAQ: DXST), an established wastewater treatment services provider in China, closed its $8…